Perinatal factors affecting growth and development at age 3 years in extremely low birth weight infants born small

Nozomi Matsuda1,2, Atsuko Taki1,2, Atsumi Tsuji1

  • 1Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Insights

Extremely low birth weight infants (ELBWIs) born small for gestational age (SGA) showed catch-up growth by age 3, but lower Apgar scores indicated risks for developmental delays. Mechanical ventilation history impacted height outcomes.

Area of Science:

  • Neonatalogy
  • Pediatric Growth and Development
  • Perinatal Medicine

Background:

  • Extremely low birth weight infants (ELBWIs) born small for gestational age (SGA) face unique challenges in growth and development.
  • Factors influencing long-term outcomes for these vulnerable infants require further elucidation.

Purpose of the Study:

  • To analyze growth and developmental trajectories of ELBWIs born SGA up to 3 years of age.
  • To identify factors associated with growth and neurodevelopmental outcomes in this cohort.

Main Methods:

  • Retrospective analysis of 244 ELBWIs born between 2003-2010.
  • Inclusion of 16 ELBWIs born SGA (weight/height <10th percentile) followed until 3 years.
  • Assessment of height, weight, and developmental quotient (DQ), with analysis of clinical factors.

Main Results:

  • At 3 years, 94% and 88% of ELBWIs achieved height and weight above -2 SD, respectively.
  • A history of mechanical ventilation was linked to height outcomes.
  • The average full developmental quotient (DQ) was 85, with 63% scoring above 85; lower Apgar scores (≤7) predicted lower DQ.

Conclusions:

  • Most ELBWIs born SGA achieve catch-up growth by age 3, surpassing the -2 SD threshold for height and weight.
  • Lower Apgar scores are a significant risk factor for impaired motor and overall development in ELBWIs born SGA.
  • Mechanical ventilation history may influence final height in this population, warranting further investigation.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
844
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.7K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.7K
The Born-Haber Cycle02:44

The Born-Haber Cycle

Lattice Energy 
25.5K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
242
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
717